The atypical antipsychotics risperidone, clozapine and olanzapine differ regarding their sedative potency in rats

被引:23
作者
Ahnaou, A [1 ]
Megens, AAHP [1 ]
Drinkenburg, WHIM [1 ]
机构
[1] Johnson & Johnson Consumer Prod Inc, Pharmaceut Res & Dev, Dept CNS Discovery Res, B-2340 Beerse, Belgium
关键词
antipsychotic; quantitative EEG analysis; sedation; rat; risperidone; clozapine; olanzapine;
D O I
10.1159/000071829
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
The atypical antipsychotics risperidone, clozapine and olanzapine were studied for their ability to antagonise apomorphine-induced stereotypy and to affect electroencephalographic (EEG) activity in rats. The compounds antagonised apomorphine-induced stereotypy with ED(50)s of 0.15 mg/kg s.c. for risperidone, 0.42 mg/kg s.c. for olanzapine and 1.3 mg/kg s.c. for clozapine. At a dose close to that required for apomorphine antagonism (0.16 mg/kg s.c.), risperidone induced only minor changes in EEG power spectral activity. At a higher dosage (0.63 mg/kg s.c.) it increased the power density in the high frequency range (9.8-18.6 Hz), characteristic of a sedative-like effect. Olanzapine and clozapine caused a dose-dependent increase in power density in all frequency bands. These effects were already present at doses (0.04 and 0.16 mg/kg s.c., respectively) 10 times below those required for apomorphine antagonism. The effects increased dose-dependently and were pronounced at the doses required for apomorphine antagonism. These results in rats are in agreement with the clinical observation that risperidone has less propensity for inducing sedation at therapeutic dose levels than olanzapine and clozapine. Copyright (C) 2003 S. Karger AG, Basel.
引用
收藏
页码:47 / 54
页数:8
相关论文
共 39 条
[1]  
ANDERSSON JL, 1994, N-S ARCH PHARMACOL, V349, P236
[2]   SUPPRESSION OF FIRING ACTIVITY OF 5-HT NEURONS IN THE DORSAL RAPHE BY ALPHA-ADRENOCEPTOR ANTAGONISTS [J].
BARABAN, JM ;
AGHAJANIAN, GK .
NEUROPHARMACOLOGY, 1980, 19 (04) :355-363
[3]   Critical analysis and comparison of the side-effect and safety profiles of the new antipsychotics [J].
Barnes, TRE ;
McPhillips, MA .
BRITISH JOURNAL OF PSYCHIATRY, 1999, 174 :34-43
[4]   SLEEP-DEPRIVATION - EFFECTS ON SLEEP AND EEG IN THE RAT [J].
BORBELY, AA ;
NEUHAUS, HU .
JOURNAL OF COMPARATIVE PHYSIOLOGY, 1979, 133 (01) :71-87
[5]   Neurochemical evidence for antagonism by olanzapine of dopamine, serotonin, alpha(1)-adrenergic and muscarinic receptors in vivo in rats [J].
Bymaster, FP ;
HemrickLuecke, SK ;
Perry, KW ;
Fuller, RW .
PSYCHOPHARMACOLOGY, 1996, 124 (1-2) :87-94
[6]  
Bymaster FP, 1997, J CLIN PSYCHIAT, V58, P28
[7]  
CHARPLEY AL, 2000, BIOL PSYCHIAT, V47, P468
[8]  
Conley RR, 2000, J CLIN PSYCHIAT, V61, P26
[9]  
Conley RR, 2000, J CLIN PSYCHIAT, V61, P20
[10]  
CZOBOR P, 1993, J CLIN PSYCHOPHARM, V13, P332